本页面由Tiger Trade Technology Pte. Ltd.提供服务

XORTX Therapeutics Inc.

2.00
-0.0400-1.96%
成交量:1,000
成交额:1,973
市值:363.31万
市盈率:-0.73
高:2.00
开:2.00
低:1.88
收:2.04
52周最高:7.05
52周最低:1.73
股本:181.66万
流通股本:178.94万
量比:0.21
换手率:0.06%
股息:- -
股息率:- -
每股收益(TTM):-2.7455
每股收益(LYR):-2.8052
净资产收益率:-99.24%
总资产收益率:-29.85%
市净率:0.66
市盈率(LYR):-0.71

数据加载中...

2026/03/20

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2026/02/13

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2026/02/13

SEC问询函

Form CORRESP - Correspondence
2025/09/25

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/05/12

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/22

SEC问询函

Form CORRESP - Correspondence
2024/11/15

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/05/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/04/28

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/01

SEC问询函

CORRESP [Cover] - Correspondence
2023/01/27

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/10/28

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/09/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/22

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/21

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/21

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/09/19

SEC问询函

CORRESP [Cover] - Correspondence
2022/09/19

SEC问询函

CORRESP [Cover] - Correspondence